Speeches, Articles and Testimony by

The following is a purely personal comment on the current controversy over merger enforcement in the United States and in Europe. It is particularly important to emphasize here that I speak only for

*The views expressed are those of the Chairman, and do not necessarily reflect the views of the Commission or of any other Commissioner. In his delivered remarks, the Chairman may deviate frequently

Good morning. Thank you Professor Rodota; and I'd also like to thank CNIL for inviting me to speak here today. At the outset, I'd like to make a few comments about the events of September 11.

On

Distinguished Guests, Families and Friends ....

I am always concerned that I will overlook someone deserving of recognition, forgive me if I have done so today. Most certainly, all here deserve

Introduction

Good afternoon. I am delighted to be here, and I am honored to be back at the FTC as its Chairman.

As many of you may know, this is my third tour at the FTC. I first served as Assistant

* Commissioner Anthony's remarks are adapted from several speeches she has made on consumer privacy. The views expressed are those of Commissioner Anthony and do not necessarily reflect the views of

Good evening. I will begin with the traditional announcement that as a Commissioner of the Federal Trade Commission (FTC), I speak only for myself, and my remarks do not necessarily represent the

Robert Pitofsky is one of the key Founding Fathers of the modern FTC. He was present at its creation, as principal author of the 1969 ABA Report on the Commission.(1) In that pivotal role, he crafted

As the title indicates, the settlement of pharmaceutical patent disputes is a subject that I have already addressed.(1) You may wonder why I am visiting it again. When I first discussed the issue last